This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pfizer Inc (PFE)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 51.58B 58.99B 67.42B 67.81B
Cost of Sales 7.78B 8.90B 11.64B 13.20B
Gross Operating Profit 43.81B 50.09B 55.78B 54.61B
Selling, General, and Administrative Expenses 14.36B 16.62B 19.47B 19.61B
Research & Development 6.68B 7.87B 9.11B 9.41B
Operating Income before D & A (EBITDA) 22.78B 25.60B 27.20B 25.59B
Depreciation & Amortization 6.41B 7.61B 9.03B 8.49B
Interest Income 403.00M 383.00M 458.00M 402.00M
Other Income - Net 964.00M 0.00 -1.26B -3.07B
Special Income / Charges 579.00M -2.89B 0.00 0.00
Total Income Before Interest Expenses (EBIT) 17.13B 13.60B 14.44B 11.22B
Interest Expense 1.41B 1.52B 1.68B 1.80B
Pre-Tax Income 15.72B 12.08B 12.76B 9.42B
Income Taxes 4.31B 2.56B 4.02B 1.12B
Minority Interest 69.00M 28.00M 42.00M 32.00M
Net Income From Continuing Operations 11.41B 9.52B 8.74B 8.30B
Net Income From Discontinued Operations 10.66B 5.08B 1.31B -9.00M
Net Income From Total Operations 22.07B 14.60B 10.05B 8.29B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 22.00B 14.57B 10.01B 8.26B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
12.01B 14.29B 11.67B 11.51B
Preferred Dividends
Net Income Available To Common 11.41B 9.52B 8.74B 8.30B
Basic EPS from Continuing Ops. 1.67 1.27 1.11 1.03
Basic EPS from Discontinued Ops. 1.56 0.68 0.17 0.00
Basic EPS from Total Operations 3.23 1.95 1.28 1.03
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.01 0.00 0.00
Basic EPS, Total 3.23 1.96 1.28 1.03
Basic Normalized Net Income/Share 1.76 1.91 1.48 1.43
EPS fr Continuing Ops. 1.65 1.26 1.11 1.02
EPS fr Discontinued Ops 1.54 0.68 0.17 0.00
EPS fr Total Ops. 3.19 1.94 1.28 1.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 -0.01 0.00
EPS, Total 3.19 1.94 1.27 1.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.74 1.89 1.48 1.42
Dividends Paid per Share 0.96 0.88 0.80 0.72
PFE News

Analysts Ratings for PFE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 6 6
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET PFE ANALYST REPORT

Brokerage Partners

PFE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs